OverviewSuggest Edit

Establishment Labs, a medical technology company, designs, develops, manufactures, and markets medical devices for aesthetic plastic surgery, reconstructive plastic surgery, and aesthetic dermatology. The Company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Divina 3D simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and distributes Puregraft line of products that is used to remove blood, lipids, and other components from adipose tissue.
TypePublic
Founded2004
HQAlajuela, CR
Websiteestablishmentlabs.com

Latest Updates

Employees (est.) (Dec 2019)602(+2%)
Revenue (FY, 2019)$89.6 M(+47%)
Share Price (Aug 2020)$17.7
Cybersecurity ratingAMore

Key People/Management at Establishment Labs

Juan José Chacón-Quirós

Juan José Chacón-Quirós

CEO & Founder
Salvador Dada

Salvador Dada

COO
Renee Gaeta

Renee Gaeta

CFO
Roberto de Mezerville

Roberto de Mezerville

Chief Technology Officer
Jeremy Livianu

Jeremy Livianu

General Counsel
Alberto Quesada

Alberto Quesada

VP of Quality & Regulatory
Show more

Establishment Labs Office Locations

Establishment Labs has offices in Alajuela and New York
Alajuela, CR (HQ)
4th Street, Coyol Free Zone
New York, US
712 Fifth Avenue, 712 5th Ave 14th Floor
Show all (4)

Establishment Labs Financials and Metrics

Establishment Labs Revenue

Embed Graph
View revenue for all periods
Establishment Labs's revenue was reported to be $89.57 m in FY, 2019
USD

Revenue (Q1, 2020)

24.5m

Gross profit (Q1, 2020)

15.5m

Gross profit margin (Q1, 2020), %

63.2%

Net income (Q1, 2020)

(17.8m)

EBIT (Q1, 2020)

(7.7m)

Market capitalization (6-Aug-2020)

413.9m

Closing stock price (6-Aug-2020)

17.7

Cash (31-Mar-2020)

93.6m
Establishment Labs's current market capitalization is $413.9 m.
Annual
USDFY, 2018FY, 2019

Revenue

61.2m89.6m

Cost of goods sold

25.1m34.7m

Gross profit

36.1m54.9m

Gross profit Margin, %

59%61%
Quarterly
USDQ2, 2018Q3, 2018Q2, 2019Q3, 2019Q1, 2020

Revenue

13.7m16.3m21.7m22.9m24.5m

Cost of goods sold

5.5m6.2m8.7m8.6m9.0m

Gross profit

8.2m10.1m13.0m14.2m15.5m

Gross profit Margin, %

60%62%60%62%63%
Annual
USDFY, 2018FY, 2019

Cash

52.6m37.7m

Accounts Receivable

17.6m22.8m

Prepaid Expenses

4.3m6.8m

Inventories

24.8m28.7m
Quarterly
USDQ2, 2018Q3, 2018Q2, 2019Q3, 2019Q1, 2020

Cash

11.6m65.6m31.9m42.6m93.6m

Accounts Receivable

16.2m18.2m21.3m22.0m21.6m

Prepaid Expenses

4.3m5.6m4.5m7.0m7.2m

Inventories

13.2m15.4m26.5m26.4m25.5m
Annual
USDFY, 2018FY, 2019

Net Income

(21.1m)(38.1m)

Inventories

(7.0m)(3.4m)

Accounts Payable

(3.9m)1.8m

Cash From Operating Activities

(33.9m)(30.0m)
Quarterly
USDQ2, 2018Q3, 2018Q2, 2019Q3, 2019Q1, 2020

Net Income

(10.6m)(19.8m)(32.6m)(17.8m)

Inventories

(1.0m)(3.3m)(725.0k)(2.0m)438.0k

Accounts Payable

(487.0k)(2.5m)2.4m3.7m366.0k

Cash From Operating Activities

(14.9m)(25.4m)(15.1m)(26.0m)(6.8m)
USDQ2, 2018

Revenue/Employee

31.3k

Debt/Equity

9.1 x

Debt/Assets

0.3 x

Financial Leverage

26.7 x
Show all financial metrics

Establishment Labs Operating Metrics

FY, 2017FY, 2018

Countries

60 60

Motiva Implants Sold to Date

446 k650 k

Product Lines

3 3
Show all operating metrics

Establishment Labs Acquisitions / Subsidiaries

Company NameDateDeal Size
Establishment Labs
Establishment Labs Produtos par Saude Ltda
European Distribution Center Motiva BVBA
JAMM Technologies
JEN-Vault AG
Motiva Implants France SAS
Motiva Implants Spain
Motiva Implants UK Limited
Motiva Italy S.R.L
Motiva Nordica AB
Show more

Establishment Labs Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Establishment Labs Online and Social Media Presence

Embed Graph

Establishment Labs News and Updates

Establishment Labs to Announce Second Quarter 2020 Financial Results on August 6

NEW YORK, July 23, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (Nasdaq: ESTA), a medical technology company focused on Women’s Health, initially in the breast aesthetics and reconstruction market, plans to announce its financial results for the quarter ended June 30, 2020 after the m…

Establishment Labs Reports Fourth Quarter and Full Year 2019 Financial Results

NEW YORK, March 16, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the fourth quarter and full year ended Decem…

Establishment Labs Announces Pricing of Public Offering of Common Shares

NEW YORK, Jan. 29, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announced the pricing of its public offering of 2,285,714 commo…

Establishment Labs Reports Third Quarter 2019 Financial Results

NEW YORK, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the third quarter ended September 30, 2019.

United States Breast Implant Market Size, Trends & Forecast 2025 Featuring Mentor, Allergan Natrelle, Sientra, Ideal Implant Incorporated, Arion Laboratories, GC Anesthetics, Establishment Labs

DUBLIN, Sept. 26, 2019 /PRNewswire/ -- The "US Breast Implant Market Size, Trends & Forecast 2025" report has been added to ResearchAndMarkets.com's offering. "US Breast Implant Market Size, Trends & Forecast 2025" Report Highlights: US Breast Implant Market Opportunity: > US$ 1 Billion..…

Establishment Labs Receives Notice of Allowance for Key U.S. Patent Application Covering Company’s Implant Surface Technology and Announces 510(k) Submission for its Tissue Expander

NEW YORK, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that the Company has received a Notice of Allowance from the U.S. Pate…
Show more

Establishment Labs Blogs

Establishment Labs Receives Issuance for Key U.S. Patent Covering Company’s Implant Surface Technology

NEW YORK, March 25, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that the U.S. Patent & Trademark Office has issued a patent protecti…

Establishment Labs to Announce Fourth Quarter 2019 Financial Results on March 16

Establishment Labs to Announce Fourth Quarter 2019 Financial Results on March 16 Ray.Beron@west.com Tue, 03/03/2020 - 08:00 Establishment Labs to Announce Fourth Quarter 2019 Financial Results on March 16 March 3, 2020 This release is a back…

ESTA Announces Participation at the Cowen and Company 40th Annual Health Care Conference

NEW YORK, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announced that CEO and Founder Juan José Chacón-Quirós will participate at the

Establishment Labs Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares

NEW YORK, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announced the closing of its previously announced public

Establishment Labs Announces Preliminary Results for Fourth Quarter and Full Year 2019; Reports Record Revenue

Establishment Labs Announces Preliminary Results for Fourth Quarter and Full Year 2019; Reports Record Revenue Content Import Tue, 01/28/2020 - 16:05 Establishment Labs Announces Preliminary Results for Fourth Quarter and Full Year 2019; Reports Record Revenue Janu…

Establishment Labs Announces Proposed Public Offering of Common Shares

Establishment Labs Announces Proposed Public Offering of Common Shares Content Import Tue, 01/28/2020 - 16:01 Establishment Labs Announces Proposed Public Offering of Common Shares January 28, 2020 This release is a backfill from a News Wire…
Show more

Establishment Labs Frequently Asked Questions

  • When was Establishment Labs founded?

    Establishment Labs was founded in 2004.

  • Who are Establishment Labs key executives?

    Establishment Labs's key executives are Juan José Chacón-Quirós, Salvador Dada and Renee Gaeta.

  • How many employees does Establishment Labs have?

    Establishment Labs has 602 employees.

  • What is Establishment Labs revenue?

    Latest Establishment Labs annual revenue is $89.6 m.

  • What is Establishment Labs revenue per employee?

    Latest Establishment Labs revenue per employee is $148.8 k.

  • Who are Establishment Labs competitors?

    Competitors of Establishment Labs include GC Aesthetics, GATT Technologies and Dianosic.

  • Where is Establishment Labs headquarters?

    Establishment Labs headquarters is located at 4th Street, Coyol Free Zone, Alajuela.

  • Where are Establishment Labs offices?

    Establishment Labs has offices in Alajuela and New York.

  • How many offices does Establishment Labs have?

    Establishment Labs has 4 offices.